Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen to delay ovulation in NC-IVF
NCT02571543Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2016
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ibuprofen, sponsored by Insel Gruppe. Primary endpoint: Percentage of non ovulated follicles at 42 hours. Started Jan 2016; status: completed.
02
Drugs
ibuprofen
Beyond the preview
Go deeper on NCT02571543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571543.